- Filed
- Aug 6, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2021 · Aug 2, 2021 | 143.45M sh |
| Cash And Equivalents | Q2 2021 · Jun 30, 2021 | $2.03M |
| Cash And Equivalents | Q2 2021 · Dec 31, 2020 | $427.9K |
| Current Liabilities | Q2 2021 · Jun 30, 2021 | $632.95K |
| Current Liabilities | Q2 2021 · Dec 31, 2020 | $399.58K |
| Total Liabilities | Q2 2021 · Jun 30, 2021 | $3.66M |
| Total Liabilities | Q2 2021 · Dec 31, 2020 | $3.38M |
| Current Assets | Q2 2021 · Jun 30, 2021 | $2.06M |
| Current Assets | Q2 2021 · Dec 31, 2020 | $477.81K |
| Total Assets | Q2 2021 · Jun 30, 2021 | $2.11M |
| Total Assets | Q2 2021 · Dec 31, 2020 | $551.79K |
| Shares Diluted | Q2 2021 · Jun 30, 2020 | 133.44M sh |
| Shares Diluted | Q2 2021 · Jun 30, 2020 | 133.27M sh |
| Operating Cash Flow | Q2 2021 · Jun 30, 2020 | −$559.63K |
| Stockholders Equity | Q2 2021 · Jun 30, 2020 | −$2.72M |
| Stockholders Equity | Q2 2021 · Mar 31, 2020 | −$2.44M |
| Stockholders Equity | Q2 2021 · Dec 31, 2019 | −$2.34M |
| Eps Diluted | Q2 2021 · Jun 30, 2020 | $0.00 |
| Eps Diluted | Q2 2021 · Jun 30, 2020 | −$0.01 |
| Eps Basic | Q2 2021 · Jun 30, 2020 | $0.00 |
| Eps Basic | Q2 2021 · Jun 30, 2020 | −$0.01 |
| Sga Expense restated | Q2 2021 · Jun 30, 2020 | $400.95K |
| Sga Expense restated | Q2 2021 · Jun 30, 2020 | $757.81K |
| Rd Expense restated | Q2 2021 · Jun 30, 2020 | $3.48K |
| Rd Expense restated | Q2 2021 · Jun 30, 2020 | $3.95K |
| Net Income | Q2 2021 · Jun 30, 2020 | −$436.16K |
| Net Income | Q2 2021 · Jun 30, 2020 | −$822.89K |
| Net Income | Q2 2021 · Mar 31, 2020 | −$386.73K |
| Operating Income | Q2 2021 · Jun 30, 2020 | −$385.24K |
| Operating Income | Q2 2021 · Jun 30, 2020 | −$723.38K |
| Revenue | Q2 2021 · Jun 30, 2020 | $19.19K |
| Revenue | Q2 2021 · Jun 30, 2020 | $38.38K |